Blood, antisera, vaccines, toxins and cultures in Germany

EXPORTS (2018): $29.7B, World Rnk 2 / 171
Flag Rnk 5 / 1217

TOP DESTINATION (2018): $6.21B, Netherlands

FASTEST GROWING MARKET (2017 - 2018): $2.29B, Netherlands

IMPORTS (2018): $19.1B, World Rnk 2 / 214
Flag Rnk 8 / 1215

TOP ORIGIN (2018): $4.18B, Switzerland

FASTEST GROWING ORIGIN (2017 - 2018): $619M, Belgium-Luxembourg

ECONOMIC COMPLEXITY of Germany (2018): 1.9, Rnk 4 / 137

PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures (2018): 1.18, Rnk 110 / 1018

Exports: In 2018, Germany exported $29.7B in Blood, antisera, vaccines, toxins and cultures, making it the 2nd largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 5th most exported product in Germany. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Germany are: Netherlands ($6.21B), United States ($3.3B), Italy ($2.93B), Switzerland ($2.46B), and United Kingdom ($1.81B).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Germany between 2017 and 2018 were Netherlands ($2.29B), Italy ($1.53B), and Switzerland ($786M).

Imports: In 2018, Germany imported $19.1B in Blood, antisera, vaccines, toxins and cultures, becoming the 2nd largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 8th most imported product in Germany. Germany imports Blood, antisera, vaccines, toxins and cultures primarily from: Switzerland ($4.18B), United States ($2.84B), Netherlands ($2.82B), Belgium-Luxembourg ($1.99B), and Ireland ($1.23B).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Germany between 2017 and 2018 were Belgium-Luxembourg ($619M), Switzerland ($528M), and Italy ($353M).

Value

EXPORTS (2018): $29.7B

IMPORTS (2018): $19.1B

NET TRADE (2018): $10.6B

In 2018, Germany exported $29.7B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Germany exports on Blood, antisera, vaccines, toxins and cultures were Netherlands ($6.21B), United States ($3.3B), Italy ($2.93B), Switzerland ($2.46B), and United Kingdom ($1.81B).

In 2018, Germany imported $19.1B in Blood, antisera, vaccines, toxins and cultures, mainly from Switzerland ($4.18B), United States ($2.84B), Netherlands ($2.82B), Belgium-Luxembourg ($1.99B), and Ireland ($1.23B).

Explore Visualizations

IN 2018, Germany HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2018, Germany HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Germany WERE (2017 - 2018):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Germany WERE (2017 - 2018):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, Germany's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2018, Germany's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Trade Forecasts

#permalink to section

Time

This section shows forecasts for total exports and imports, for Blood, antisera, vaccines, toxins and cultures in Germany. The forecast is based on a short-term, medium-term and long-term model using yearly trade data.

Explore Forecasts

Tariffs by Country

#permalink to section

In 2017, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Germany were of 0% around the world.

Explore Tariff Data